ONO Pharmaceutical Co Ltd (JP:4528)
:4528
Want to see JP:4528 full AI Analyst Report?
Total Valuation
ONO Pharmaceutical Co has a market cap or net worth of ¥1.15T. The enterprise value is ¥1.04T.
Market Cap¥1.15T
Enterprise Value¥1.04T
Share Statistics
ONO Pharmaceutical Co has 498,692,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding498,692,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
ONO Pharmaceutical Co’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.65%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)5.65%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee126.36M
Profits Per Employee12.99M
Employee Count3,853
Asset Turnover0.46
Inventory Turnover2.02
Valuation Ratios
The current PE Ratio of ONO Pharmaceutical Co is 16.9. ONO Pharmaceutical Co’s PEG ratio is 0.43.
PE Ratio16.9
PS Ratio2.29
PB Ratio1.39
Price to Fair Value0.96
Price to FCF9.02
Price to Operating Cash Flow―
PEG Ratio0.43
Income Statement
In the last 12 months, ONO Pharmaceutical Co had revenue of 486.87B and earned 50.05B in profits. Earnings per share was 106.55.
Revenue486.87B
Gross Profit335.47B
Operating Income63.38B
Pretax Income59.33B
Net Income50.05B
EBITDA90.28B
Earnings Per Share (EPS)106.55
Cash Flow
In the last 12 months, operating cash flow was 85.02B and capital expenditures -6.14B, giving a free cash flow of 78.88B billion.
Operating Cash Flow85.02B
Free Cash Flow78.88B
Free Cash Flow per Share158.18
Dividends & Yields
ONO Pharmaceutical Co pays an annual dividend of ¥40, resulting in a dividend yield of 3.63%
Dividend Per Share¥40
Dividend Yield3.63%
Payout Ratio77.50%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change67.81%
50-Day Moving Average2.43K
200-Day Moving Average2.07K
Relative Strength Index (RSI)50.06
Average Volume (3m)2.41M
Important Dates
ONO Pharmaceutical Co upcoming earnings date is Aug 3, 2026, TBA (Confirmed).
Last Earnings DateMay 8, 2026
Next Earnings DateAug 3, 2026
Ex-Dividend Date―
Financial Position
ONO Pharmaceutical Co as a current ratio of 3.07, with Debt / Equity ratio of ―
Current Ratio3.07
Quick Ratio2.56
Debt to Market Cap0.18
Net Debt to EBITDA-0.64
Interest Coverage Ratio38.77
Taxes
In the past 12 months, ONO Pharmaceutical Co has paid 9.16B in taxes.
Income Tax9.16B
Effective Tax Rate0.15
Enterprise Valuation
ONO Pharmaceutical Co EV to EBITDA ratio is 7.70, with an EV/FCF ratio of 9.02.
EV to Sales1.43
EV to EBITDA7.70
EV to Free Cash Flow9.02
EV to Operating Cash Flow8.43
Balance Sheet
ONO Pharmaceutical Co has ¥139.98B in cash and marketable securities with ¥120.94B in debt, giving a net cash position of ¥1.87B billion.
Cash & Marketable Securities¥139.98B
Total Debt¥120.94B
Net Cash¥1.87B
Net Cash Per Share¥3.75
Tangible Book Value Per Share¥930.34
Margins
Gross margin is ―, with operating margin of 13.02%, and net profit margin of 10.28%.
Gross Margin―
Operating Margin13.02%
Pretax Margin12.19%
Net Profit Margin10.28%
EBITDA Margin18.54%
EBIT Margin13.02%
Analyst Forecast
The average price target for ONO Pharmaceutical Co is ¥1,900.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target¥1,900.00
Price Target Upside-16.39% Downside
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast5.94%
EPS Growth Forecast39.34%